Conference Description:
By attending Immunogenicty you will be able to:
*Assess the very latest developments within predictive testing for immunogenicity, including characterising families of monoclonal antibodies for accurate prediction
*Understand the challenges and opportunities posed within detection and characterisation of immunogenicity and analyse the latest technologies to enable accurate detection and characterisation
*Ensuring investment into lab automation to cut development timelines
*Implement the latest regulatory changes to ensure compliance
Internationally Renowned Confirmed speakers Include:
*Dr Albert Torri, Senior Director, Assay Development and Sample Analysis, Preclinical Development, Regeneron Pharmaceuticals
*Dr Birgit Reipert, Director, Immunology, Global Preclinical R&D
Baxter
*Dr Huub Schellkens, Department of Innovation Studies, University College London